title: Feline Pit2 functions as a receptor for subgroup B feline leukemia viruses.
abstract: Different subgroups of feline leukemia virus (FeLV) use different host cell receptors for entry. Subgroup A FeLV (FeLV-A) is the virus that is transmitted from cat to cat, suggesting that cells expressing the FeLV-A receptor are important targets at the earliest stages of infection. FeLV-B evolves from FeLV-A in the infected cat through acquisition of cellular sequences that are related to the FeLV envelope gene. FeLV-Bs have been shown to infect cells using the Pit1 receptor, and some variants can infect cells at a lower efficiency using Pit2. Because these observations were made using receptor proteins of human or rodent origin, the role that Pit1 and Pit2 may play in FeLV-B replication in the cat is unclear. In this study, the feline Pit receptors were cloned and tested for their ability to act as receptors for different FeLV-Bs. Some FeLV-Bs infected cells expressing feline Pit2 and feline Pit1 with equal high efficiency. Variable region A (VRA) in the putative receptor-binding domain (RBD) was a critical determinant for both feline Pit1 and feline Pit2 binding, although other domains in the RBD appear to influence how efficiently the FeLV-B surface unit can bind to feline Pit2 and promote entry via this receptor. An arginine residue at position 73 in VRA was found to be important for envelope binding to feline Pit2 but not feline Pit1. Interestingly, this arginine is not found in endogenous FeLV sequences or in recombinant viruses recovered from feline cells infected with FeLV-A. Thus, while FeLV-Bs that are able to use feline Pit2 can evolve by recombination with endogenous sequences, a subsequent point mutation during reverse transcription may be needed to generate a virus that can efficiently enter the cells using the feline Pit2 as its receptor. These studies suggest that cells expressing the feline Pit2 protein are likely to be targets for FeLV-B infection in the cat.
authors.affiliation: Division of Human Biology, Fred Hutchinson Cancer Research Center, University of Washington, Seattle, 98109-1024, USA.
authors.forename: M M
authors.initials: MM
authors.lastname: Anderson
authors.forename: A S
authors.initials: AS
authors.lastname: Lauring
authors.forename: S
authors.initials: S
authors.lastname: Robertson
authors.forename: C
authors.initials: C
authors.lastname: Dirks
authors.forename: J
authors.initials: J
authors.lastname: Overbaugh
mesh_terms: D000595:Amino Acid Sequence; D000818:Animals; D005075:Biological Evolution; D002415:Cats; D002460:Cell Line; D006801:Humans; D005256:Leukemia Virus, Feline / Q000145:classification*; D008969:Molecular Sequence Data; D011991:Receptors, Virus / Q000737:chemistry / Q000502:physiology*
chemical_list: D011991:Receptors, Virus; C074548:feline leukemia virus receptor; C067981:leukemia virus receptor, gibbon ape